RecruitingNCT06247163

PET-guided Radiotherapy for Patients With Small Cell Lung Cancer.

Prospective PET-guided Radiotherapy for Patients With Small Cell Lung Cancer.


Sponsor

University Hospital, Essen

Enrollment

30 participants

Start Date

Feb 22, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

There is a prospective risk-adapted evaluation of the optimal dose of radiotherapy for definitive radiotherapy of locally advanced small cell lung cancer within the corridor recommended as standard therapy according to the current interdisciplinary S3 guideline of the German Cancer Society/Cancer Aid/AWMF


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is using PET scan imaging to guide radiation therapy decisions for people with limited-stage small cell lung cancer (a fast-growing type of lung cancer that has not spread beyond the chest). The goal is to tailor the radiation treatment plan based on what the PET scan reveals, potentially improving targeting and reducing unnecessary radiation to healthy tissue. **You may be eligible if...** - You have been diagnosed with small cell lung cancer confirmed by tissue biopsy - Your cancer is limited stage (contained within one side of the chest and lymph nodes, not spread widely) - Your general health is adequate (ECOG performance status of 0, 1, or 2) **You may NOT be eligible if...** - You have a different type of lung cancer (not small cell) - You have another concurrent cancer diagnosis - Your general health is very poor (ECOG 3 or worse) - Your cancer is extensive stage (spread beyond the chest to distant sites) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONPET based Raditherapy boost

An Interim PET CT will be performed. If there is residual vital tumor, a higher radiation dose will be applied.


Locations(1)

University Hospital Essen

Essen, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06247163


Related Trials